D007004

2 trials

Sponsors

Tanaka Masami, Kaneto Hideaki

Conditions

Type 2 Diabetes Mellitus Diabetes Mellitus, Type 2Type 2 diabetes mellitus Diabetes Mellitus, Type 2

Unknown Phase

The Study of Effect of antidiabetic agents on pancreatic beta-Cell REsponsiveness To glucose; comparative Evaluation of DPP-4 Inhibitors and SGLT2 inhibitor, Luseogliflozin

Active, not recruitingJPRN-jRCTs061190008

Kaneto HideakiType 2 Diabetes Mellitus Diabetes Mellitus, Type 2

Start: 2019-07-10Target: 114Updated: 2025-07-18

RESTORE-nephropathy study

Active, not recruitingJPRN-jRCTs031190185

Tanaka MasamiType 2 diabetes mellitus Diabetes Mellitus, Type 2

Start: 2020-01-14Target: 47Updated: 2025-07-18

Related Papers

Comparison of protective effects of teneligliptin and luseogliflozin on pancreatic β-cell function: randomized, parallel-group, multicenter, open-label study (SECRETE-I study)

Frontiers in Endocrinology2024-10-212 citations

886-P: Protective Effects of DPP-4 Inhibitor and SGLT2 Inhibitor on Pancreatic ß-Cell Function—Randomized, Parallel-Group, Multicenter, Open-Label Study (SECRETE-I)

Diabetes2023-06-20